Recombination of Globally Circulating Varicella-Zoster Virus

被引:58
|
作者
Norberg, Peter [1 ]
Depledge, Daniel P. [2 ]
Kundu, Samit [2 ]
Atkinson, Claire [3 ]
Brown, Julianne [4 ]
Haque, Tanzina [3 ]
Hussaini, Yusuf [5 ]
MacMahon, Eithne [6 ]
Molyneaux, Pamela [7 ]
Papaevangelou, Vassiliki [8 ]
Sengupta, Nitu [9 ]
Koay, Evelyn S. C. [10 ]
Tang, Julian W. [11 ]
Underhill, Gillian S. [12 ]
Grahn, Anna [1 ]
Studahl, Marie [1 ]
Breuer, Judith [2 ]
Bergstrom, Tomas [1 ]
机构
[1] Univ Gothenburg, Dept Infect Dis, Sect Clin Virol, Inst Biomed, Gothenburg, Sweden
[2] MRC, Ctr Med Mol Virol, Div Infect & Immun, London, England
[3] Royal Free Hosp, Dept Virol, London NW3 2QG, England
[4] Great Ormond St Hosp Children NHS Fdn Trust, Camelia Botnar Labs, Microbiol Virol & Infect Prevent & Control, London, England
[5] Ahmadu Bello Univ, Dept Microbiol, Zaria, Kaduna State, Nigeria
[6] Guys & St Thomas NHS Fdn Trust, St Thomas Hosp, Dept Infect Dis, London, England
[7] Aberdeen Royal Infirm, Dept Med Microbiol, Aberdeen, Scotland
[8] Univ Athens, Sch Med, Univ Gen Hosp ATTIKON, Dept Pediat 3, GR-11527 Athens, Greece
[9] Ealing Serv Children Addit Needs, London, England
[10] Natl Univ Singapore Hosp, Mol Diag Ctr, Dept Lab Med, Singapore 117548, Singapore
[11] Univ Hosp Leicester NHS Trust, Clin Microbiol, Leicester, Leics, England
[12] Queen Alexandra Hosp, Dept Clin Microbiol, Portsmouth, Hants, England
基金
英国医学研究理事会;
关键词
INFECTIOUS LARYNGOTRACHEITIS; PHYLOGENETIC ANALYSIS; GENETIC-RECOMBINATION; ATTENUATED VACCINES; HERPES-ZOSTER; DNA-SEQUENCE; GENOTYPES; STRAINS; EPIDEMIOLOGY; DIVERSITY;
D O I
10.1128/JVI.00437-15
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Varicella-zoster virus (VZV) is a human herpesvirus, which during primary infection typically causes varicella (chicken pox) and establishes lifelong latency in sensory and autonomic ganglia. Later in life, the virus may reactivate to cause herpes zoster (HZ; also known as shingles). To prevent these diseases, a live-attenuated heterogeneous vaccine preparation, vOka, is used routinely in many countries worldwide. Recent studies of another alphaherpesvirus, infectious laryngotracheitis virus, demonstrate that live-attenuated vaccine strains can recombine in vivo, creating virulent progeny. These findings raised concerns about using attenuated herpesvirus vaccines under conditions that favor recombination. To investigate whether VZV may undergo recombination, which is a prerequisite for VZV vaccination to create such conditions, we here analyzed 115 complete VZV genomes. Our results demonstrate that recombination occurs frequently for VZV. It thus seems that VZV is fully capable of recombination if given the opportunity, which may have important implications for continued VZV vaccination. Although no interclade vaccine-wild-type recombinant strains were found, intraclade recombinants were frequently detected in clade 2, which harbors the vaccine strains, suggesting that the vaccine strains have already been involved in recombination events, either in vivo or in vitro during passages in cell culture. Finally, previous partial and complete genomic studies have described strains that do not cluster phylogenetically to any of the five established clades. The additional VZV strains sequenced here, in combination with those previously published, have enabled us to formally define a novel sixth VZV clade. IMPORTANCE Although genetic recombination has been demonstrated to frequently occur for other human alphaherpesviruses, herpes simplex viruses 1 and 2, only a few ancient and isolated recent recombination events have hitherto been demonstrated for VZV. In the present study, we demonstrate that VZV also frequently undergoes genetic recombination, including strains belonging to the clade containing the vOKA strain.
引用
收藏
页码:7133 / 7146
页数:14
相关论文
共 50 条
  • [21] SEROEPIDEMIOLOGY OF VARICELLA-ZOSTER VIRUS INFECTION IN ALBANIA
    Bejtja, Gazmend
    Robo, Alma
    Harxhi, Arjan
    INTERNATIONAL JOURNAL OF ECOSYSTEMS AND ECOLOGY SCIENCE-IJEES, 2015, 5 (02): : 213 - 216
  • [22] Varicella-Zoster Virus Infection and Osteomyelitis of the Skull
    Sommer, Taylor
    Karsy, Michael
    Driscoll, Meghan J.
    Jensen, Randy L.
    WORLD NEUROSURGERY, 2018, 115 : 297 - 300
  • [23] Posterior horn varicella-zoster virus myelitis
    R. Toledano
    J. López-Sendón
    F. Gilo
    E. Riva
    J. Martínez-San Millán
    J. Masjuán
    Journal of Neurology, 2007, 254 : 400 - 401
  • [24] Genomic sequencing revealed recombination event between clade 1 and clade 2 occurs in circulating varicella-zoster virus in China
    Li, Jia
    Wang, Dan
    Qi, Libin
    Yang, Yuewu
    Pei, Jiawei
    Dong, Yangchao
    Wang, Yuan
    Yao, Min
    Zhang, Fanglin
    Lei, Yingfeng
    Cheng, Linfeng
    Ye, Wei
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2024, 55 (01) : 125 - 132
  • [25] Varicella-Zoster Virus Vaccine: Molecular Genetics
    Schmid, D. Scott
    VARICELLA-ZOSTER VIRUS, 2010, 342 : 323 - 340
  • [26] Varicella-Zoster Virus and the Enteric Nervous System
    Gershon, Michael
    Gershon, Anne
    JOURNAL OF INFECTIOUS DISEASES, 2018, 218 : S113 - S119
  • [27] Vaccines against varicella-zoster virus (VZV)
    Salleras, Luis
    Salleras, Montserrat
    Soldevila, Nuria
    Prat, Andreu
    Garrido, Patricio
    Dominguez, Angela
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2015, 33 (06): : 411 - 423
  • [28] Molecular Aspects of Varicella-Zoster Virus Latency
    Depledge, Daniel P.
    Sadaoka, Tomohiko
    Ouwendijk, Werner J. D.
    VIRUSES-BASEL, 2018, 10 (07):
  • [29] VARICELLA-ZOSTER VIRUS VACCINE, SUCCESSES AND DIFFICULTIES
    Sarkadi, Julia
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2013, 60 (04) : 379 - 396
  • [30] Seroprevalence of varicella-zoster virus in the German population
    Wutzler, P
    Färber, I
    Wagenpfeil, S
    Bisanz, H
    Tischer, A
    VACCINE, 2001, 20 (1-2) : 121 - 124